| Catalog Number |
9-PFO-025 |
| Medical Device Problem Code |
Adverse Event Without Identified Device or Use Problem (2993)
|
| Health Effect - Clinical Codes |
Stroke/CVA (1770); Movement Disorder (4412)
|
| Date of Event |
06/18/2023
|
|
Type of Reportable Event
|
Serious Injury
|
|
Event or Problem Description
|
|
Clinical information: crd_961 - pfo japan pas, patient site id:(b)(6).It was reported that a 25mm amplatzer pfo occluder was implanted on (b)(6) 2021.P2y12 inhibitor (antiplatelet) and direct oral anticoagulants (doac) were prescribed post-procedure.On (b)(6) 2023, during a 2-year patient follow-up no issues were detected and the patient was only prescribed antiplatelet.On (b)(6) 2023 the patient experienced an ischemic stroke and presented with paralysis in the upper and lower extremities and aphasia.The patient was rushed to the hospital and administered edaravone.The symptoms were reportedly resolved.It was believed that the stroke was unrelated to the device and procedure.The patient status was stable.
|
| |
|
Additional Manufacturer Narrative
|
|
Investigation is not yet complete.A follow-up report will be submitted with all additional relevant information.
|
| |
|
Additional Manufacturer Narrative
|
|
An event of ischemic stroke and paralysis in the upper and lower extremities and aphasia after two years of device implant was reported.A returned device assessment could not be performed as the device remains implanted and was not returned for analysis.It was reported that the patient was hospitalized and medication was administered, the symptoms were reportedly resolved.Based on the information received, the cause of the reported incident could not be conclusively determined.The device history record was reviewed to ensure that each manufacturing and inspection operation was performed and the product met all specifications.There is no indication of a product quality issue with respect to labeling design or manufacturing of the device.
|
| |
|
Search Alerts/Recalls
|